Artificial Intelligence Doctor App Ada Health Closes $90M Funding Led By Bayer, Samsung

German digital health firm Ada Health has raised a $90 million funding round at an undisclosed valuation bringing total investment in the company up to around $150 million.
The company has received backing from Bayer AG’s BAYRY Leaps by Bayer investment arm, while Samsung Electronics SSNGY invested through the Samsung Catalyst Fund.
Samsung Electronics’ former chief strategy officer and corporate president, Young Sohn, has joined Ada Health’s board.
Ada Health has developed a doctor-in-your-pocket-style app that uses artificial intelligence to diagnose symptoms.
Founded in 2011, Ada Health’s app has been downloaded over 11 million times.
“The app basically works like a WhatsApp chat with your trusted family doctor, but 24/7” Nathrath, CEO of Ada Health, told CNBC.
The patient starts by entering their symptoms, and an AI chatbot will ask a series of questions to determine the issue.
After that, the app will present the patient with the conditions that are most likely to be the cause and offer some suggestions.
The iOS and Android apps give generic advice, such as seeing a general practitioner in the next three days.
But when patients interact with Ada Health through a health system that uses the app, they can go straight into booking an appointment and sharing the outcome of their pre-assessment with a real doctor, Nathrath said.
Many companies such as Axa OneHealth, Novartis AG NVS, Pfizer Inc PFE, and SutterHealth are all listed as partners on Ada Health’s website.
While the app is free for patients to download, Ada Health charges partners for access to its software.
Last week, Alphabet Inc GOOG announced a web tool that uses artificial intelligence to help people identify skin, hair, or nail conditions.

Market News and Data brought to you by Benzinga APIs

Comments

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga